Miss Nicola Fearnhead FRCS
Consultant Colorectal Surgeon – Addenbrooke’s Hospital, Cambridge UK
Nicola Fearnhead is President Elect of the Association of Coloproctology of Great Britain & Ireland, taking over as President in July 2019.
She has been a Consultant Colorectal Surgeon at Addenbrooke’s Hospital, Cambridge since 2006. She studied medicine at Pembroke College, Cambridge and Merton College, Oxford where she was a Rhodes Scholar. Surgical training was undertaken in Bristol and Oxford followed by an International Fellowship in Advanced Colorectal Surgery at the Cleveland Clinic in Ohio during 2005.
Clinical interests include advanced pelvic malignancy and exenteration surgery, transanal endoscopic microsurgery, management of anal cancer including salvage surgery, inflammatory bowel disease and especially perianal Crohn’s disease, rectovaginal fistula repair, and functional consequences of treatments on patient quality of life.
Nicola is active in several areas of clinical research, having led the ACPGBI’s development of a research strategy with integrated patient and public involvement (the Delphi Research Programme) while Chair of ACPGBI’s Research & Audit Committee from 2013-2017. She was awarded the Patient Liaison Group’s Patient Champion Award in 2017. She has been a member of the NCRI Colorectal CSG surgical subgroup since 2014 and was appointed Chair of the subgroup in 2018. She is Principal Investigator for several portfolio trials. She currently serves on the trial management groups of HiP, CReST2, PREPARE-ABC and STAR-TREC, and on the independent data monitoring committee of OPERA.
Nicola served as Honorary Secretary of ACPGBI’s IBD Clinical Advisory Group from 2016 to 2018, co-authored the 2017 Ileoanal Pouch Report and co-edited the 2018 ACPGBI Guidelines in IBD Surgery. She leads the multidisciplinary researcher and patient collaborative group ENiGMA which focusses on research for the benefit of patients with fistulating perianal Crohn’s disease. She has facilitated several meetings between patients and researchers to promote patient involvement in research.
She is Clinical Co-Lead of the National Bowel Cancer Audit, having previously chaired the Clinical Advisory Group for the National Bowel Cancer Audit from 2014 to 2018 and led the national programme for Consultant Outcome Publication in bowel cancer surgery on behalf of the ACPGBI from 2014 to 2016.
She was selected for the RCS Emerging Leader’s programme in 2015 and now sits on the RCS Research & Fellowships Committee. She chairs the Steering Group for the trainee-led National Audit of SBO, and currently sits on the steering committee of the NCEPOD Acute Bowel Obstruction enquiry. She is a Trustee of the Bowel Disease Research Foundation, and medical adviser to the peer support charities Bowel Cancer UK and Crohn’s and Colitis UK.
In 2017, Nicola led the ACPGBI’s IMPACT (Improving Management of Patients with Advanced Colorectal Tumours) initiative, which is now delivering a national quality improvement programme in partnership with the Pelican Cancer Foundation.
She recently joined the Programme Committee for ESCP. She was invited to Cape Town as the Visiting Penman Lecturer in 2019. Nicola is very supportive of the concept of Tripartite and has contributed both to the first Tripartite 2020 Vision collaboration on Low Anterior Resection Syndrome as well as leading the Tripartite 2020 Vision prioritisation of research questions.